Valuence Merger Corp I (VMCA) - Net Assets
Based on the latest financial reports, Valuence Merger Corp I (VMCA) has net assets worth $9.96 Million USD as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($22.85 Million) and total liabilities ($12.90 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Valuence Merger Corp I liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $9.96 Million |
| % of Total Assets | 43.56% |
| Annual Growth Rate | 768.04% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 689511.36 |
Valuence Merger Corp I - Net Assets Trend (2021–2024)
This chart illustrates how Valuence Merger Corp I's net assets have evolved over time, based on quarterly financial data. Also explore Valuence Merger Corp I assets under control for the complete picture of this company's asset base.
Annual Net Assets for Valuence Merger Corp I (2021–2024)
The table below shows the annual net assets of Valuence Merger Corp I from 2021 to 2024. For live valuation and market cap data, see Valuence Merger Corp I market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $9.87 Million | -82.79% |
| 2023-12-31 | $57.37 Million | -73.97% |
| 2022-12-31 | $220.43 Million | +1462596.09% |
| 2021-12-31 | $15.07K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Valuence Merger Corp I's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1232594200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $22.21 Million | 224.97% |
| Total Equity | $9.87 Million | 100.00% |
Valuence Merger Corp I Competitors by Market Cap
The table below lists competitors of Valuence Merger Corp I ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Pyxis Oncology Inc
NASDAQ:PYXS
|
$86.55 Million |
|
Gowing Bros Ltd
AU:GOW
|
$86.57 Million |
|
Mangold Fondkommission AB
ST:MANG
|
$86.65 Million |
|
Insight Molecular Diagnostics Inc.
NASDAQ:IMDX
|
$86.66 Million |
|
First US Bancshares Inc
NASDAQ:FUSB
|
$86.50 Million |
|
Graha Layar Prima Tbk
JK:BLTZ
|
$86.49 Million |
|
Freetrailer Group A/S
ST:FREETR
|
$86.49 Million |
|
IBI Lion SOCIMI S.A.
MC:YIBI
|
$86.48 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Valuence Merger Corp I's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 57,368,566 to 9,871,315, a change of -47,497,251 (-82.8%).
- Net income of 2,403,129 contributed positively to equity growth.
- Share repurchases of 49,900,380 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $2.40 Million | +24.34% |
| Share Repurchases | $49.90 Million | -505.51% |
| Total Change | $- | -82.79% |
Book Value vs Market Value Analysis
This analysis compares Valuence Merger Corp I's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.67x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 20570.67x to 4.67x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $0.00 | $12.40 | x |
| 2022-12-31 | $8.82 | $12.40 | x |
| 2023-12-31 | $3.13 | $12.40 | x |
| 2024-12-31 | $2.65 | $12.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Valuence Merger Corp I utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 24.34%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 2.26x
- Recent ROE (24.34%) is above the historical average (-7.87%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -65.89% | 0.00% | 0.00x | 42.17x | $-11.44K |
| 2022 | 1.76% | 0.00% | 0.00x | 1.05x | $-18.16 Million |
| 2023 | 8.32% | 0.00% | 0.00x | 1.22x | $-965.39K |
| 2024 | 24.34% | 0.00% | 0.00x | 2.26x | $1.42 Million |
Industry Comparison
This section compares Valuence Merger Corp I's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $224,857,490
- Average return on equity (ROE) among peers: 3.02%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Valuence Merger Corp I (VMCA) | $9.96 Million | -65.89% | 1.30x | $86.52 Million |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $230.18 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $265.09 Million |
| Ares Acquisition Corporation II (AACT) | $11.15K | -0.14% | 45.93x | $587.05 Million |
| AA Mission Acquisition Corp. (AAM) | $1.54 Billion | 21.89% | 4.12x | $409.92K |
| Altenergy Acquisition Corp (AEAE) | $214.04 Million | 5.44% | 0.10x | $72.25 Million |
| Activate Energy Acquisition Corp. Class A Ordinary Share (AEAQ) | $223.53 Million | 0.00% | 0.04x | $235.74 Million |
| Aimei Health Technology Co., Ltd Ordinary Share (AFJK) | $69.76 Million | 0.25% | 0.01x | $163.82 Million |
| Aifeex Nexus Acquisition Corporation (AIFE) | $86.16 Million | -0.10% | 0.01x | $91.13 Million |
| AI TRANSPORTATION ACQUISITION CORP Ordinary shares (AITR) | $-4.24K | 0.00% | 0.00x | $86.22 Million |
| Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares (ALCY) | $115.20 Million | 2.86% | 0.05x | $49.57 Million |
About Valuence Merger Corp I
Valuence Merger Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in developing breakthrough technology in life sciences and/or advancing a platform for sustainable technology in Asia. The company was incorporated in 2021 and is base… Read more